Targeted nanoparticles to deliver combinations of calcium channel inhibitors to prevent myelin damage during secondary degeneration after neurotrauma

Project Details

StatusFinished
Effective start/end date1/01/1531/12/18

Funding

  • National Health & Medical Research Council NHMRC: A$861,300.00